Prognostic value of myeloperoxidase in patients with chest pain. - Wikidata - wikimedia - TriplyDB

Prognostic value of myeloperoxidase in patients with chest pain.

Prognostic value of myeloperoxidase in patients with chest pain.

http://www.wikidata.org/entity/Q34271813

about

Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes Can tissue-based immune markers be used for studying the natural history of cancer?The molecular mechanisms of the thrombotic complications of atherosclerosis Pentoxifylline for vascular health: a brief review of the literature Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Protein carbamylation and cardiovascular disease Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine Cardiac biomarkers: new tools for heart failure management Tyrosine modifications in aging Basic MR relaxation mechanisms and contrast agent design 3-nitrotyrosine modified proteins in atherosclerosis Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors HDL-apoA-I exchange: rapid detection and association with atherosclerosis The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.The vascular effects of infection in Pediatric Stroke (VIPS) Study.Targeted subendothelial matrix oxidation by myeloperoxidase triggers myosin II-dependent de-adhesion and alters signaling in endothelial cells.A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo.Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells Quick identification of acute chest pain patients study (QICS).Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study Magnetic nanoparticle biosensors.Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity.Dysfunctional HDL as a diagnostic and therapeutic target Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.Bioluminescence imaging of myeloperoxidase activity in vivo.Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects The knowledge-integrated network biomarkers discovery for major adverse cardiac events Optimization based tumor classification from microarray gene expression data.Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification Targeted probes for cardiovascular MRI Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.

P2860

Q21342799-FDE22B6E-7A96-4DE1-9517-5F18F991A1AF Q24605537-A1128D7D-EBE3-4B98-8FE2-C5192B614768 Q24656816-6B06ED8E-6BB6-4CFF-B97A-2AC2312E88BD Q26766371-D833449E-D296-4599-9EA7-738EBFB98866 Q26777641-3EE03D18-45E8-4A18-824D-B36A8B114D34 Q26827410-625FB8DF-F982-4226-9DE4-4E628C09CB3E Q26863117-1A327A8A-C5BC-4D44-865D-B623170F5FA8 Q26991726-769529C5-C57B-4694-8DD9-534B0BB34F97 Q26998450-86347646-1B57-4A47-A1F3-1BAD6714305E Q27692546-7320963B-2297-4E7B-BFFD-8C1A1A88CCF6 Q28083260-5F30F063-85D2-41E2-A103-9BCE4045120D Q28200597-80076562-FD38-41DC-978B-F2CEB162FD7C Q28244928-8114FBDA-B38D-4370-8CFA-B53E56CD6404 Q28287127-71100002-881C-472E-B95E-D1E89779B086 Q28535779-FB7BAE9E-1E6F-4D84-A227-F93B9A896EFC Q30240734-B59167BE-4FEB-44FB-B74A-AF7C4EE807A4 Q30425204-CCEF5DC6-56DF-449A-B800-B9B2B11F0F7D Q30530606-B63654BB-E753-4D51-BD82-413654A7BB71 Q30562239-836B3CB5-CF2D-433E-9B4A-801EB1A88BBD Q31060150-38BBDC4E-A0D5-48A0-99D3-8224981007BE Q33467558-C7FDC103-6318-47FC-80AC-4D57A4310A05 Q33530066-99C54816-508C-42DC-9A84-AF7318AD8968 Q33545705-2BE9F885-D54A-4C4C-AE19-CE17B9E69652 Q33575669-EB637C2F-1692-4AC5-8DF0-22C7FFCAD1CD Q33604003-628D399E-7DA9-4730-B978-07224966C26C Q33621941-BACD9BA3-2442-4859-9A20-A0E551637737 Q33675617-5CC4C2CD-36BE-4DD2-9CE0-5C3F41765446 Q33688005-3459827D-DB0C-4127-904E-2AA97E1ADE57 Q33691689-453C6C72-8B5E-46E7-9ACB-303FCE942AD9 Q33691730-E5A27479-94FC-474C-8D6C-212C3DE45ED2 Q33700977-E64A9D12-4209-4F9D-9954-F1609DFA7782 Q33706806-69B5D9D5-BBC7-4F56-BB83-3B0D500BFDBD Q33709886-E3DEAFC2-7595-4783-9418-83D909E62556 Q33722676-3CED7AB0-B622-4C7F-AA60-063225AE8CE4 Q33723943-33E1E692-2220-4E20-99D5-F05400F33114 Q33789038-B639B015-7058-4100-B313-3FD305C93149 Q33822080-68F199C3-3B13-4036-80E7-70A9FABB9431 Q33858743-D2E47584-C8FA-4A4E-B235-580B16F71B84 Q33901726-A9FD5D42-5012-4FB7-9E38-1865B1FE7BDA Q33922502-ACCB4F30-2637-4763-8549-1552D8246025

P2860

Prognostic value of myeloperoxidase in patients with chest pain.

http://www.wikidata.org/entity/Q34271813

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Prognostic value of myeloperoxidase in patients with chest pain.

@ast

Prognostic value of myeloperoxidase in patients with chest pain.

@en

Prognostic value of myeloperoxidase in patients with chest pain.

@nl

type

label

Prognostic value of myeloperoxidase in patients with chest pain.

@ast

Prognostic value of myeloperoxidase in patients with chest pain.

@en

Prognostic value of myeloperoxidase in patients with chest pain.

@nl

prefLabel

Prognostic value of myeloperoxidase in patients with chest pain.

@ast

Prognostic value of myeloperoxidase in patients with chest pain.

@en

Prognostic value of myeloperoxidase in patients with chest pain.

@nl

P1433

Q34271813-93E33DC0-3C77-4498-988E-4086C8FA40F6

P1476

Q34271813-DF963F02-9255-40C8-91C1-2E9C972B431A

P2093

Q34271813-11B08BE8-F144-4B0D-9BAD-2ECD1D12C020

Q34271813-1289E4DA-AC72-41BD-92AC-54CADF46E65A

Q34271813-57BD7AA8-2983-49F5-9B60-8850640B3ADA

Q34271813-602557FA-3FDF-4094-B250-244DCA2C731B

Q34271813-92CD4F56-C06E-4AB4-A175-CFA12F06F538

Q34271813-A6660AD9-F1EE-497E-908A-B85C641D9CAD

Q34271813-B0A13981-1630-4B9E-B2EF-D8E502087924

Q34271813-BC029EB2-2C58-42F8-82C9-E5952BC724A9

Q34271813-C1141C3F-6CCB-4C6E-96C5-F3986EF5CA6E

Q34271813-C1E6F4C5-B74E-4B4A-B867-8DEE5C5786B8

P304

Q34271813-B28BBB18-2EB4-412D-81CE-FEFC02E0FFE9

P31

Q34271813-2A2878FC-1F25-4D10-BF7A-3603327ABB9E

P356

Q34271813-C110EE9A-1E14-4590-8B26-14A65589CFEA

P407

Q34271813-8943D0FA-A40C-4128-BE5E-5A76657D8930

P433

Q34271813-112142E9-05F1-41EE-B779-81567F851CAF

P478

Q34271813-09F22167-8E2B-4539-B16B-F7B074AFBBA7

P50

Q34271813-BEEF71E6-CBFC-4584-BFDD-8ABE82881D04

P577

Q34271813-940F55CA-C6BD-47B0-AFBA-2310383189A2

P698

Q34271813-98ED8EF5-9E52-4D5B-9D7A-9B218A0402C5

P921

Q34271813-B63F3E2A-B89E-4494-8E6A-250D4EFC176A

P356

P1433

The New England Journal of Medicine

P1476

Prognostic value of myeloperoxidase in patients with chest pain.

@en

P2093

Ellen S McErlean

http://www.w3.org/2001/XMLSchema#string

Frederick Van Lente

http://www.w3.org/2001/XMLSchema#string

Marc S Penn

http://www.w3.org/2001/XMLSchema#string

Marie-Luise Brennan

http://www.w3.org/2001/XMLSchema#string

Marlene Goormastic

http://www.w3.org/2001/XMLSchema#string

Mehdi H Shishehbor

http://www.w3.org/2001/XMLSchema#string

Michael L Pepoy

http://www.w3.org/2001/XMLSchema#string

Ronnier J Aviles

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

Steven E Nissen

http://www.w3.org/2001/XMLSchema#string

P304

1595-1604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA035003

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14573731

http://www.w3.org/2001/XMLSchema#string

P921